
Novavax Inc (NASDAQ:NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue.
Novavax reported quarterly revenue of $222.2 million, which was down from $279.66 million year-over-year. The company reported a quarterly earnings loss of $11.18 per share, which was worse than the loss of $2.70 per share in the fourth quarter of 2020.